RCM
AVNR

Reynolds Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Reynolds Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,600
Closed -$46K – 413
2014
Q1 		$46K Sell
12,600
-2,300
-15% -$8.77K 0.03% 378
2013
Q4 		$50K Buy
14,900
+100
+0.7% +$413 0.03% 427
2013
Q3 		$63K Buy
+14,800
New +$70.1K 0.04% 407

Other funds holding AVNR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Reynolds Capital Management's AVNR Position: Q2 2014 in Review

Reynolds Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q2 2014, closing a stake of 12,600 shares — an estimated $46K sold.

Reynolds Capital Management first reported a position in AVNR in Q3 2013 and held it in 3 quarters. The position peaked at $63K in Q3 2013. 115 funds tracked by Wall St. Rank hold AVNR as of Q2 2014.

  • Reynolds Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q2 2014 after selling out during the quarter.
  • Reynolds Capital Management sold 12,600 AVANIR PHARMACEUTICALS, INC CL A shares in Q2 2014, an estimated $46K.
  • Reynolds Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 3 quarters.
  • Reynolds Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $63K in Q3 2013.
  • 115 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q2 2014.

Based on Reynolds Capital Management's 13F filing for Q2 2014, filed 8 Jul 2014.